PCN6 A COST-EFFECTIVENESS ANALYSIS OF ADJUVANT THERAPY WITH EXEMESTANE, ANASTROZOLE, LETROZOLE OR TAMOXIFEN IN POSTMENOPAUSAL WOMEN WITH EARLYSTAGE BREAST CANCER IN MEXICO
May 1, 2007, 00:00
10.1016/S1098-3015(10)68917-6
https://www.valueinhealthjournal.com/article/S1098-3015(10)68917-6/fulltext
Title :
PCN6 A COST-EFFECTIVENESS ANALYSIS OF ADJUVANT THERAPY WITH EXEMESTANE, ANASTROZOLE, LETROZOLE OR TAMOXIFEN IN POSTMENOPAUSAL WOMEN WITH EARLYSTAGE BREAST CANCER IN MEXICO
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)68917-6&doi=10.1016/S1098-3015(10)68917-6
First page :
Section Title :
Open access? :
No
Section Order :
96